Pfizer scraps second attempt at weight loss pill

Pfizer
Pfizer has decided to "discontinue development" of the weight loss pill
Molly Bowcott

Read more by Molly Bowcott

Molly Bowcott joined C+D as a digital reporter in October 2024 after graduating from a master’s in journalism at City, University of London. She previously worked as a news reporter at the U.S. Sun, covering business, politics and money.

Latest from Clinical

More from News